Bomed Medical Blames Research Spending for Loss
- Share via
Blaming continued high research spending, Bomed Medical Manufacturing Ltd. on Monday said it posted a net loss of $207,780 during the first quarter compared to a net loss of $139,320 during the first quarter of 1985. Revenues for the quarter fell 9% to $151,370 from $166,090 a year ago.
The Irvine maker of instruments for monitoring heart and circulatory systems also announced the election of Charles W.P. Kamanski to its board of directors at its April 22 meeting. At the same time, Bomed said, D.P. Strohm and P.P. Tong resigned from the board.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
